Clinical Trials Directory

Trials / Completed

CompletedNCT01280409

Metformin Postpartum for GDM RCT for Reduced Weight Retention

The Effects of Metformin on Retained Postpartum Weight in Women With Gestational Diabetes: A Randomized, Placebo-Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
114 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and whether there are any increased risks of side effects to you as a new mother.

Detailed description

At 24-48 hours after delivery, women who are eligible for participation will be approached and consented to the study. Maternal weight will be measured and 20ml of maternal blood will be obtained to assess glucose control and lipid profile. Women will be counseled regarding diet, exercise and glucose control. Data including maternal demographics, clinical characteristics and neonatal outcomes will be collected. At 3 weeks postpartum, a research nurse will contact the subject via telephone call to inquire about adverse or side effects, ability to take the prescribed medication (metformin or placebo), and to answer questions about the study. At 6 weeks postpartum, maternal weight will be measured , blood will be obtained and side effects will be evaluated again. Finally, a satisfaction survey will be completed.

Conditions

Interventions

TypeNameDescription
DRUGMetforminSubjects will receive metformin 850 mg PO daily for 7 days, then metformin 850mg PO twice a day for the next 5 weeks
DRUGPlaceboSubjects will receive a placebo (similar in size, taste, color) once daily for 7 days, then twice daily for the next 5 weeks.

Timeline

Start date
2011-01-01
Primary completion
2014-03-01
Completion
2014-08-01
First posted
2011-01-20
Last updated
2018-11-28
Results posted
2018-11-28

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01280409. Inclusion in this directory is not an endorsement.